MEDPAL AI is trading 10.16% down at £4.60, with no clear company-specific explanation found for the October 20, 2026 move.

  • The latest company update highlighted New Health’s Mounjaro supplier ranking and customer growth, rather than negative news.
  • European shares were weak, but the available market context does not establish that broader sentiment caused the decline.